Search academic texts

Information × Registration Number 0219U005544, 0117U003014 , R & D reports Title To develop a system for predicting of origin and treatment slipped capital femoral epiphysis and its complications. popup.stage_title Head Kabatsiy Myroslav Stepanovych, Кандидат медичних наук Registration Date 09-12-2019 Organization Ukrainian scientific-research institute for traumatology and orthopaedics popup.description2 Based on an analysis of the course of the disease and its outcome in 249 patients with slipped capital femoral epiphysis, it was found that the expression of miR-21 in whole blood in patients with slipped capital femoral epiphysis is excellent (mean expression of 0.86 um. ) from those of healthy donors (mean is (mean is 0.393 U) of a similar age range (p <0.05), which may indicate the role of epigenetic factors in the emergence slipped capital femoral epiphysis. The methodology for determining the period of sexual development of children and adolescents by the radiographs of the pelvis and hip joints has been developed (patent patent for utility model №u201903309 from 01.04.2019). The methodology of examination of patients with slipped capital femoral epiphysis, which includes the definition of biomarkers of the disease - hormonal, X-ray morphometric and genetic. It is based on the development of the slipped capital femoral epiphysis treatment system, depending on the impact on its course of risk factors, as well as the system of prevention and treatment of complications of the slipped capital femoral epiphysis. Product Description popup.authors Батанова Н.Є. Герцен І.Г. Голюк Є.Л. Гошко В..Ю. Лазарєв І.А. М.С. Кабацій Максімишин О.М. Мельник М.В. Мороз Д.М. Немеш М.М. Філіпчук В.В. popup.nrat_date 2020-04-02 Close